Market Tracker

04/20 6:02pm ET

Merrimack Pharmaceuticals Inc (NASDAQ:MACK)

During the Trading Day
12.71 -0.375 / -2.87%
As of 3:59pm ET
Day’s Change
During After-Hours   Switch to standard view »
12.80 +0.09 / +0.71%
 
Volume: 11.3K

Today’s Trading

Previous close13.09
Today’s open13.14
Day’s range12.53 - 13.14
Volume1,230,313
Average volume (3 months)1,450,936
Market cap$1.4B
Dividend yield--
Data as of 3:59pm ET, 04/20/2015

Growth & Valuation

Earnings growth (last year)+39.39%
Earnings growth (this year)-24.17%
Earnings growth (next 5 years)+5.61%
Revenue growth (last year)+115.03%
P/E ratioNM
Price/Sales11.48
Price/Book--

Competitors

 Today’s
change
Today’s
% change
INSMInsmed Inc+0.45+1.99%
TTPHTetraphase Pharmaceu...-0.39-0.98%
ACORAcorda Therapeutics ...+0.40+1.16%
USNAUSANA Health Science...+2.00+1.70%
Data as of 4:02pm ET, 04/20/2015

Financials

Next reporting dateMay 12, 2015
EPS forecast (this quarter)-$0.29
Annual revenue (last year)$102.8M
Annual profit (last year)-$83.3M
Net profit margin-81.06%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Robert J. Mulroy
Head-
Corporate Operations
William M. McClements
Corporate headquarters
Cambridge, Massachusetts

Forecasts